TCL Archive Johnson, Katterhagen Applaud CCOP RFA But With It Had Money For More Cancer Control July 30, 1982
TCL Archive De-Emphasis of Tradition Grants Still Haunts Some; “Recent NCI Actions Held Up As Evidence May 21, 1976
TCL Archive In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches October 24, 1980
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
